Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Johnson & Johnson Pharmaceuticals is a leading healthcare company in China, primarily engaged in the manufacturing and commercialization of over-the-counter (OTC) medications. As a subsidiary of Kenvue (the consumer health spin-off of Johnson & Johnson), the company operates a major production facility in Shanghai's Minhang District. Its product portfolio includes globally recognized brands such as Tylenol, Motrin, and Rhinocort, which address widespread needs in pain management, pediatrics, and respiratory health. The company is a cornerstone of the Chinese consumer pharmaceutical market, maintaining rigorous GMP standards to ensure the safety and efficacy of its treatments. It continues to play a pivotal role in expanding access to essential self-care products for millions of consumers across the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Johnson Pharmaceutical.